MC
IBB icon

Moors & Cabot’s iShares Biotechnology ETF IBB Stock Holding History

Moors & Cabot’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-30,000
Closed -$30K – 656
2019
Q3 		$30K Buy
+30,000
New +$3.14M ﹤0.01% 625

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Moors & Cabot's IBB Position: Q2 2026 in Review

Moors & Cabot increased its iShares Biotechnology ETF (IBB) stake by 0.88% in Q2 2026, buying an estimated $13.8K and bringing the position to 9,121 shares worth $1.73M. The position accounts for 0.07% of the portfolio, ranked #260.

Moors & Cabot first reported a position in IBB in Q1 2014 and has held it in 44 quarters since. The position peaked at $4.57M in Q2 2021. 957 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Moors & Cabot held 9,121 shares of iShares Biotechnology ETF worth $1.73M as of Q2 2026.
  • Moors & Cabot bought 80 iShares Biotechnology ETF shares in Q2 2026, an estimated $13.8K.
  • iShares Biotechnology ETF made up 0.07% of Moors & Cabot's portfolio in Q2 2026, its #260 holding.
  • Moors & Cabot first reported a position in iShares Biotechnology ETF in Q1 2014 and has held it in 44 quarters since.
  • Moors & Cabot's iShares Biotechnology ETF position peaked at $4.57M in Q2 2021.
  • 957 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.